234 related articles for article (PubMed ID: 22236408)
1. Targeting sphingosine kinase-1 to inhibit melanoma.
Madhunapantula SV; Hengst J; Gowda R; Fox TE; Yun JK; Robertson GP
Pigment Cell Melanoma Res; 2012 Mar; 25(2):259-74. PubMed ID: 22236408
[TBL] [Abstract][Full Text] [Related]
2. Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma.
Madhunapantula SV; Sharma A; Gowda R; Robertson GP
Pigment Cell Melanoma Res; 2013 Nov; 26(6):886-99. PubMed ID: 24034838
[TBL] [Abstract][Full Text] [Related]
3. Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth.
Xue Y; Jiang K; Ou L; Shen M; Yang Y; Lu J; Xu W
Cell Death Dis; 2022 Jul; 13(7):602. PubMed ID: 35831279
[TBL] [Abstract][Full Text] [Related]
4. Dual role of sphingosine kinase-1 in promoting the differentiation of dermal fibroblasts and the dissemination of melanoma cells.
Albinet V; Bats ML; Huwiler A; Rochaix P; Chevreau C; Ségui B; Levade T; Andrieu-Abadie N
Oncogene; 2014 Jun; 33(26):3364-73. PubMed ID: 23893239
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.
LeBlanc FR; Liu X; Hengst J; Fox T; Calvert V; Petricoin EF; Yun J; Feith DJ; Loughran TP
Cancer Biol Ther; 2015; 16(12):1830-40. PubMed ID: 26252351
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.
Li W; Li J; Wang Y; Zhang K; Li N; Tian Z; Ni B; Wang H; Ruan Z
Oncotarget; 2016 Dec; 7(49):80586-80598. PubMed ID: 27811359
[TBL] [Abstract][Full Text] [Related]
7. A sphingosine kinase-1 inhibitor, SKI-II, induces growth inhibition and apoptosis in human gastric cancer cells.
Li PH; Wu JX; Zheng JN; Pei DS
Asian Pac J Cancer Prev; 2014; 15(23):10381-5. PubMed ID: 25556479
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade.
Martin JL; de Silva HC; Lin MZ; Scott CD; Baxter RC
Mol Cancer Ther; 2014 Feb; 13(2):316-28. PubMed ID: 24337110
[TBL] [Abstract][Full Text] [Related]
9. Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia.
Powell JA; Lewis AC; Zhu W; Toubia J; Pitman MR; Wallington-Beddoe CT; Moretti PA; Iarossi D; Samaraweera SE; Cummings N; Ramshaw HS; Thomas D; Wei AH; Lopez AF; D'Andrea RJ; Lewis ID; Pitson SM
Blood; 2017 Feb; 129(6):771-782. PubMed ID: 27956387
[TBL] [Abstract][Full Text] [Related]
10. SphK1/S1P Mediates PDGF-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation via miR-21/BMPRII/Id1 Signaling Pathway.
Li F; Wang J; Zhu Y; Liu L; Feng W; Shi W; Wang Q; Zhang Q; Chai L; Li M
Cell Physiol Biochem; 2018; 51(1):487-500. PubMed ID: 30453304
[TBL] [Abstract][Full Text] [Related]
11. Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro.
Yao C; Wu S; Li D; Ding H; Wang Z; Yang Y; Yan S; Gu Z
Mol Oncol; 2012 Aug; 6(4):392-404. PubMed ID: 22583777
[TBL] [Abstract][Full Text] [Related]
12. Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells.
Xu L; Zhang Y; Gao M; Wang G; Fu Y
Biochem Biophys Res Commun; 2016 Apr; 472(4):662-8. PubMed ID: 26920060
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis.
Karimian G; Buist-Homan M; Schmidt M; Tietge UJ; de Boer JF; Klappe K; Kok JW; Combettes L; Tordjmann T; Faber KN; Moshage H
Biochim Biophys Acta; 2013 Dec; 1832(12):1922-9. PubMed ID: 23816565
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells.
Leroux ME; Auzenne E; Evans R; Hail N; Spohn W; Ghosh SC; Farquhar D; McDonnell T; Klostergaard J
Prostate; 2007 Nov; 67(15):1699-717. PubMed ID: 17879964
[TBL] [Abstract][Full Text] [Related]
15. The sphingosine kinase inhibitor SKI-V suppresses cervical cancer cell growth.
Zhang Y; Cheng L; Shi X; Song Y; Chen XY; Chen MB; Yao J; Zhang ZQ; Cai S
Int J Biol Sci; 2022; 18(7):2994-3005. PubMed ID: 35541904
[TBL] [Abstract][Full Text] [Related]
16. The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target.
Wang X; Sun Y; Peng X; Naqvi SMAS; Yang Y; Zhang J; Chen M; Chen Y; Chen H; Yan H; Wei G; Hong P; Lu Y
Cancer Control; 2020; 27(1):1073274820976664. PubMed ID: 33317322
[TBL] [Abstract][Full Text] [Related]
17. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.
Yang L; Weng W; Sun ZX; Fu XJ; Ma J; Zhuang WF
Biochem Biophys Res Commun; 2015 May; 460(4):903-8. PubMed ID: 25824043
[TBL] [Abstract][Full Text] [Related]
18. Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma.
Chen MH; Yen CC; Cheng CT; Wu RC; Huang SC; Yu CS; Chung YH; Liu CY; Chang PM; Chao Y; Chen MH; Chen YF; Chiang KC; Yeh TS; Chen TC; Huang CY; Yeh CN
Oncotarget; 2015 Sep; 6(27):23594-608. PubMed ID: 26090720
[TBL] [Abstract][Full Text] [Related]
19. [Sphingosine kinase 1 and tumor].
Zhang CX; He HW; Shao RG
Yao Xue Xue Bao; 2013 Jul; 48(7):971-8. PubMed ID: 24133963
[TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo.
Cholewa BD; Ndiaye MA; Huang W; Liu X; Ahmad N
Cancer Lett; 2017 Jan; 385():179-187. PubMed ID: 27793694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
